These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 720380)

  • 1. Transplacental passage of atenolol in man.
    Melander A; Niklasson B; Ingemarsson I; Liedholm H; Scherstén B; Sjöberg NO
    Eur J Clin Pharmacol; 1978 Nov; 14(2):93-4. PubMed ID: 720380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Food-induced reduction in bioavailability of atenolol.
    Melander A; Stenberg P; Liedholm H; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1979 Nov; 16(5):327-30. PubMed ID: 520399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.
    Fitzgerald JD; Ruffin R; Smedstad KG; Roberts R; McAinsh J
    Eur J Clin Pharmacol; 1978 May; 13(2):81-9. PubMed ID: 658112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplacental transfer of polycyclic aromatic hydrocarbons in paired samples of maternal serum, umbilical cord serum, and placenta in Shanghai, China.
    Zhang X; Li X; Jing Y; Fang X; Zhang X; Lei B; Yu Y
    Environ Pollut; 2017 Mar; 222():267-275. PubMed ID: 28024810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, pharmacology of atenolol and effect of renal disease.
    Wan SH; Koda RT; Maronde RF
    Br J Clin Pharmacol; 1979 Jun; 7(6):569-74. PubMed ID: 465278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide distribution, transplacental passage, and accumulation in the amniotic fluid during the third trimester of pregnancy.
    Bourget P; Pons JC; Delouis C; Fermont L; Frydman R
    Ann Pharmacother; 1994 Sep; 28(9):1031-4. PubMed ID: 7803877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplacental passage and breast milk concentrations of hydralazine.
    Liedholm H; Wåhlin-Boll E; Hanson A; Ingemarsson I; Melander A
    Eur J Clin Pharmacol; 1982; 21(5):417-9. PubMed ID: 7200428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone.
    Riva E; Farina PL; Sega R; Tognoni G; Bastain W; McAinsh J
    Eur J Clin Pharmacol; 1980 May; 17(5):333-7. PubMed ID: 7418712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atenolol in the treatment of pregnancy-induced hypertension.
    Thorley KJ; McAinsh J; Cruickshank JM
    Br J Clin Pharmacol; 1981 Nov; 12(5):725-30. PubMed ID: 7332738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer of propranolol and sotalol across the human placenta. Their effect on maternal and fetal plasma renin activity.
    Erkkola R; Lammintausta R; Liukko P; Anttila M
    Acta Obstet Gynecol Scand; 1982; 61(1):31-4. PubMed ID: 7046334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.
    Houtzagers JJ; Streurman O; Regårdh CG
    Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?
    Ohman I; Vitols S; Tomson T
    Epilepsia; 2005 Oct; 46(10):1621-4. PubMed ID: 16190933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-course of transplacental passage of diazepam: Influence of injection-delivery interval on neonatal drug concentrations.
    Bakke OM; Haram K
    Clin Pharmacokinet; 1982; 7(4):353-62. PubMed ID: 7116737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and absolute bioavailability of atenolol.
    Mason WD; Winer N; Kochak G; Cohen I; Bell R
    Clin Pharmacol Ther; 1979 Apr; 25(4):408-15. PubMed ID: 428185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay.
    Wellstein A; Palm D; Belz GG; Leopold G; Bühring KU; Pabst J
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S41-5. PubMed ID: 2439797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
    Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery.
    Calhoun DA; Rosa C; Christensen RD
    Am J Obstet Gynecol; 1996 Apr; 174(4):1306-11. PubMed ID: 8623861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, beta-blockade and steady-state pharmacokinetics.
    Ishizaki T; Oyama Y; Suganuma T; Sasaki T; Nakaya H; Shibuya T; Sato T
    Br J Clin Pharmacol; 1983 Jul; 16(1):17-25. PubMed ID: 6349668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal and uteroplacental haemodynamics during short-term atenolol treatment of hypertension in pregnancy.
    Montan S; Liedholm H; Lingman G; Marsál K; Sjöberg NO; Solum T
    Br J Obstet Gynaecol; 1987 Apr; 94(4):312-7. PubMed ID: 3580313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability in man of atenolol and chlorthalidone from a combination formulation.
    McAinsh J; Bastain W; Young J; Harry JD
    Biopharm Drug Dispos; 1981; 2(2):147-56. PubMed ID: 7248478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.